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 Abstract
BACKGROUND: Major depressive disorder (MDD) is a leading cause for morbidity and mortality. Whey protein 
components are recently used as functional foods with health benefits. Alpha-lactalbumin (A-LA) is an important 
component of whey protein. It is a good source of the essential amino acids.
OBJECTIVE: This study aimed to examine the possible antidepressant effect of whey protein against MDD induced 
by chronic unpredictable stress (CUS) in mice.
MATERIALS AND METHODS: CUS model is used to induce depression in mice for 24 consecutive days and 
aimed to evaluate the ability of A-LA compared to fluoxetine to recover depression symptoms. Thirty minutes before 
exposure to the physical stressor, mice were given A-LA daily in a dose of 75, 150, and 300 mg/kg bwt.
RESULTS: The highest dose of A-LA (300 mg/kg bwt.) lessens depression induced in mice.
CONCLUSION: This effect might contribute to elevate the level of glutamate and monoamine neurotransmitters, 
γ-amino-butyric acid inhibition, and enhancement of glutathione in brain tissue.
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Introduction
Major depressive disorder (MDD) is a determined 
psychiatric illness which might cause physical impairment. 
Approximately 350 million people around the world suffer 
from MDD, whereas about 15 million people at the United 
States are affected with this mental illness [1].
According to monoamine hypothesis, the 
deficiency of neurotransmitters directly contributes to the 
arising of MDDs. The antidepressant drugs act by inhibition 
of reuptake of neurotransmitters as selective serotonin 
(SE) reuptake inhibitors of tricyclic antidepressants or 
inhibiting degradation of monoamine neurotransmitters, 
for example, monoamine oxidase inhibitors [2].
Genetic factors as well can contribute to the 
pathogenesis of depression. The synergism between 
environmental stress and susceptible genes motivates 
the incidence of MDD [3]. Oxidative stress has also 
been implicated in the pathophysiology of MDD and that 
the antidepressant activity can be mediated through the 
improvement of oxidative stress/antioxidant function [4].
Whey and casein are proteins available in milk. 
Curds are made from casein while whey remains in an 
aqueous form [5].
Alpha-lactalbumin (A-LA) is one of the most 
valuable components of whey protein. A-LA is rich 
in cysteine, tryptophan (Trp), and glutamine. These 
are essential amino acid used by the body to 
produce glutathione (GSH), SE, and glutamate (Glu), 
respectively. Trp is an essential amino acid that should 
be supplied from external source as it is not synthesized 
in the body. Trp is the precursor of the neurotransmitter 
SE and the precursor to melatonin which is a hormone 
involved in the sleep-wake cycle. SE was found to 
control the appetite, mood, sleep regulation, cognitive 
performance, and the ability to cope with stress [6].
The chronic unpredictable stress (CUS) 
procedure mimics the role of chronic stress in precipitating 
MDD and induces long-term neurochemical, behavioral, 
neuroendocrine, and physical alterations resembling 
those noticed in depressed patients [7].
In previous investigations in our lab we had 
demonstrated an antidepressant effect for whey protein 
in rats [8]. A-LA represents one of the major constituents 
of whey protein and is considered one of the most 
important sources of Trp, the precursor of SE which is a 
chef neurotransmitter involved in depression. Previously, 
the effect of administrating A-LA has been evaluated as 
antidepressant acting by increasing the brain content of SE.
Since the three neurotransmitters involved in 
depression (SE, norepinephrine [NE], and dopamine 
[DA]) were found to be interconnected, our study aimed 
to investigate the beneficial effect of A-LA administration 
A - Basic Sciences Pharmacology
94 https://www.id-press.eu/mjms/index
on brain levels of DA and NE as well as its potential 
effect in ameliorating the depressive symptoms.
Materials and Methods
Animals and drugs
Adult male Swiss albino mice, weighing 20–25 g, 
obtained from the Animal Breeding Unit at National 
Research Centre (NRC, Giza, Egypt). Mice were kept 
under standard conditions of natural 12 h light and dark 
cycle and allowed free access to food and water. Mice 
were allowed to adapt to the laboratory environment for 
1 week before conducting of behavioral experiments. All 
experimental procedures were approved from the ethical 
committee of the National Research Centre and according 
to the recommendations of the proper care and use of 
laboratory animals and following the recommendations of 
the National Institutes of Health guide for Care and Use of 
Laboratory Animals (Publication No. 85-23, revised 1985).
Drugs
Fluoxetine hydrochloride (Prozac 20 mg 
dispersible tablets, Lilly, Spain). The tablets were freshly 
suspended in distilled water before oral administration.
A-LA was provided as a generous gift from 
Davisco Foods International Inc. and it was provided 
as pure powder for ingestion. The powder was freshly 
dissolved in distilled water just before oral administration.
CUS model
Mice were randomly assigned into six groups 
of 10 individuals: Normal control receiving oral distilled 
water, depressed control administered oral distilled 
water plus CUS, A-LA groups receiving orally A-LA 
at dose levels of 75, 150, and 300 mg/kg plus CUS, 
and standard drug group orally given fluoxetine 10 mg/
kg. Normal control group was housed in a separate 
room, did not have any contact with the stressed 
animals, and was undisturbed except for necessary 
procedures such as routine cage cleaning. All other 
groups were subjected to CUS procedure for a period 
of 24 days, where the mice were subjected each day 
to one of six physical stressors for 30 min after the 
corresponding drug ingestion. The CUS procedure was 
performed as described by Mao et al. (2009) [7] with 
a slight modification [9]. Briefly, CUS consisted of a 
variety of unpredictable stressors, namely, 24-h water 
deprivation, 6-min cold swimming (at 8°C), 1-min tail 
pinch (1 cm from the end of the tail), 2-h restraint, 24-h 
soiled cage (200 mL water in 100 g sawdust bedding), 
and overnight illumination. One of these stressors (in 
random order) was given every day for 24 days.
Behavioral tests
Twenty-four hours after the last stressor behavioral 
tests were performed; these include open-field test (OFT), 
tail suspension test (TST), and forced swim test.
OFT
The OFT was carried out in a square wooden 
arena (40 cm × 40 cm × 40cm high) with red walls and 
white smooth polished floor divided by black lines into 
16 equal squares. The test was performed under white 
light in a quiet room. Each mouse was placed at the 
same corner square and observed during 5 min [10]. The 
floor and walls were cleaned after testing each mouse. 
The following parameters were recorded during 5 min 
observation period: Latency: Time taken by each animal 
till it starts moving in the arena, ambulation frequency: 
Number of squares crossed by the animal, rearing 
frequency: Number of times the animal stood stretched 
on its hind limbs with or without forelimb support, and 
grooming frequency: Number of face scratching and 
washing with the hind limbs and licking of the forelimbs.
TST
The TST is based on the observation that a 
mouse suspended by the tail shows alternate periods of 
agitation and immobility. Each mouse was suspended 
by its tail from a steel bar using an adhesive tape placed 
approximately 1 cm from the tip of the tail, the distance 
between floor and tail was about 30 cm. The total 
duration of immobility during a 6-min test was measured. 
Mice were considered immobile only when they hung 
passively in a completely motionless state [11].
Forced swimming test (FST)
 In this method, each mouse was forced to 
swim in a restricted space from which it cannot escape 
according to the method described by. After the initial 
phase of vigorous activity, swimming attempts cease 
and the animal adopts a characteristic immobile posture 
in which it floats in an upright position making only 
movements necessary to keep its head above water. 
Each mouse was placed for 6 min in a cylindrical water 
tank which was transparent, and it had a diameter of 
18 cm and height of 25 cm. The water level was about 
15 cm and water temperature was maintained at 25 ± 
1°C. The total duration of immobility of each animal in 
the past 4 min was recorded. The tank was emptied 
and washed with fresh water flush between each mice 
to remove any traces of urine or feces [12].
Biochemical analysis
Twenty-four hours after the completion of 
behavioral tests, mice were sacrificed by decapitation. 
Brains were isolated and each brain was washed with 
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sterile cold physiological saline, blotted between two 
damp filter papers, and stored at −80°C until the use for 
biochemical analysis.
Determination of brain amino acids and 
monoamines
Each brain tissue was weighed and 
homogenized in 1/10 weight/volume of 75% aqueous 
high-performance liquid chromatography (HPLC) grade 
methanol [13]. The homogenate was spun at 4000 r.p.m. 
for 10 min and the supernatant was divided into two 
halves; the first was dried using vacuum (70 millipore) 
at room temperature and used for γ-amino-butyric acid 
(GABA) and Glu determination, whereas the second 
half was used for monoamine determination.
Brain Glu and GABA were detected by HPLC 
using the precolumn PTC derivatization technique [14]. 
Brain monoamines were detected by HPLC [15].
Determination of malondialdehyde (MDA) and 
GSH
Each brain tissue was homogenized in ice-
cold saline (20% w/v). The homogenate was divided 
into two portions for the determination of MDA and 
GSH levels [16], [17]. MDA is an end product of 
lipid peroxidation that reacts with thiobarbituric acid 
producing thiobarbituric acid reactive substance, a pink 
chromogen is determined spectrophotometrically at 
532 nm, an MDA standard was used to make a standard 
curve. GSH determination is based on the reduction of 
5,5-dithiobis (2-nitrobenzoic acid) with reduced GSH to 
produce a yellow compound. The reduced chromogen 
is directly proportional to GSH concentration and 
its absorbance can be measured at 405 nm using a 
commercial kit that was used (Biodiagnostic, Egypt).
Statistical analysis
Statistical analysis was performed by one-way 
analysis of variance ANOVA followed by least significant 
difference test (LSD test). Data are expressed as means 
± standard error of mean where any two groups were 
considered significantly different if the difference between 
their mean values was more that the corresponding LSD 
value stated for each experiment at p < 0.05.
Results
Behavioral studies
OFT
Group subjected to CUS model showed a 
significant decrease in the ambulation, rearing, and 
grooming frequencies to 57.2%, 34.94%, and 42.86%, 
respectively, compared to normal control. On the other 
hand, the latency time increased to 453.6% as compared 
to normal control. Group given fluoxetine restored the 
latency time and ambulation frequency to normal level, 
while the rearing frequency increased to 237.93% 
as compared to a depressed group, the grooming 
frequency increased up to 134.01% as compared to 
normal control. The three-dose levels of A-LA (75, 150, 
and 300 mg/kg) significantly decreased the latency 
time to 67.48%, 49.46%, and 34.25%, respectively, 
compared to the depressed control. Treatment with 
A-LA in a dose of 75 mg/kg significantly increased the 
ambulation and rearing frequencies to 148.33% and 
217.59%, respectively, compared to the depressed 
group and normalized the grooming frequency. A-LA 
(150 mg/kg) elevated the rearing frequency to 225.52% 
while the ambulation and grooming frequencies are 
restored to normal levels as compared to normal 
control group. A-LA (300 mg/kg) normalized the rearing 
frequency and it increased the ambulation and the 
grooming frequencies up to 111.67% and 136.05% of 
the normal group, respectively (Figure 1a and b).
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Figure 1:(a) Latency time in open-field test. Values represent the 
mean%. @p < 0.05: Statistically significant from normal control,*p < 0.05: 
Statistically significant from depressed group, (b) Ambulation, rearing, 
and grooming frequencies in open-field test values represent the 
mean%. (n = 10). @p < 0.05: Statistically significant from normal 
control,*p < 0.05: Statistically significant from depressed group
a
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FST
Group subjected to CUS model showed a 
significant increase in the immobility duration (98.5 ± 
8.69 s) as compared to normal control. Group given 
fluoxetine restored immobility duration to normal values. 
Groups given A-LA in a dose of 75 and 150 mg/kg bwt. 
significantly decreased the immobility duration when 
compared to depressed group (38.17% and 16.55%, 
respectively). On the other hand, it was evident that 
A-LA (300 mg/kg) returned the immobility duration to 
the normal value (Figure 2).
HPLC determination of SE, NE, and DA in 
brain tissue
Group subjected to CUS model reported 
a significant decrease in SE, NE, and DA levels as 
compared to normal control (44.8%, 36.1%, and 
63.3%, respectively). Group given fluoxetine showed 
significant increase in SE, NE. and DA (117%, 94.5%. 
and 101.3%. respectively) as compared to normal 
control. Group given A-LA in a dose of 75 mg/kg bwt. 
increased SE significantly (180.8%) when compared 
to depressed groups while NE and DA were restored 
to normal levels. Meanwhile, A-LA (150 mg/kg) 
normalized the SE and NE contents and showed 
a significant increase in the DA level (126.67%) 
compared to the normal control. On the other hand, 
treatment with A-LA (300 mg/kg) restored the normal 
SE level and significantly increased the NE and DA 
contents to 158.64% and 212.67% of normal control, 
respectively (Figure 4).
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Figure 4: Determination of serotonin, norepinephrine, and dopamine. 
Values represent the mean % of five mice for each group (n = 10). 
@p < 0.05: Statistically significant from normal control, *p < 0.05: 
Statistically significant from depressed group
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Figure 2: Forced swimming test. Values represent the mean % of five 
mice for each group (n = 10). @p < 0.05: Statistically significant from 
normal control,*p < 0.05: Statistically significant from depressed group
TST
Group subjected to CUS model showed a 
significant increase in the immobility duration up to 140.8 
± 6.14 s as compared to normal control. Group given 
fluoxetine restored immobility duration to normal level. 
Groups given A-LA in a dose of 75 and 150 mg/kg bwt. 
showed a significant decrease in the immobility duration 
when compared to depressed group (54.54% and 
46.59%, respectively). A-LA in a dose of 300 mg/kg bwt. 
restored the immobility duration to normal level (Figure 3).
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Figure 3: Tail suspension test. Values represent the mean % of five 
mice for each group (n = 10). @p < 0.05: Statistically significant from 
normal control, *p < 0.05: Statistically significant from depressed group
HPLC determination of GABA and Glu in 
brain tissue
Depressed mice showed a significant elevation 
in GABA level (202.9%) while Glu level was significantly 
decreased (27.9%) when compared to control normal. 
Group given fluoxetine on the contrary showed 
a significant decrease in GABA and a significant 
decrease in Glu level (71% and 193.7%, respectively) 
as compared to control normal. Oral administration of 
all the three doses of A-LA repossessed the normal 
level of GABA and regarding the Glu level, although the 
dose level (75 mg/kg) did not have any effect on Glu 
compared to the depressed group, A-LA (150 mg/kg) 
reinstated its normal level, while A-LA (300 mg/kg) 
significantly elevated the Glu level up to 175.05% of the 
normal control (Figure 5).
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Effect of A-LA on brain MDA and reduced 
GSH in CUS-depressed mice
GSH level was significantly decreased in 
depressed mice to 47.5% of the normal control. On the 
other hand, MDA level was significantly elevated up to 
124.5% when compared to control group. On the contrary, 
mice given fluoxetine restored the level of GSH and MDA 
to normal levels. Treatment with A-LA (75 mg/kg and 
150 mg/kg) significantly increased the GSH level up to 
146.45% and 189.83% as compared to depressed mice, 
administration of A-LA in a dose of 300 mg/kg restored 
the normal GSH level. Moreover, treatment with A-LA 
(75 mg/kg) retrieved the MDA level while A-LA (150 mg/
kg and 300 mg/kg) significantly decreased the MDA level 
to 62.29% and 56.72%, respectively, as compared to the 
depressed group (less than the normal level by 22.41% 
and 29.35%, respectively), as shown in Figure 6.
Discussion
Chronic stress is believed to be a compelling 
factor involved in depression onset and relapse. 
CUS was found to induce long-term neurochemical, 
behavioral, neuroendocrine, and physical alterations 
resembling those noticed in depressed patients. OPT, 
FST, and TST are the most impeccable tests to evaluate 
the efficacy of new antidepressant drugs [7], [18].
The present data reported that depression 
by CUS model reduced ambulation, rearing, and 
grooming frequencies and increased the latency time 
in the OFT, indicating the prevalence of depression. 
These results are in agreement with a previous study 
[19] where a decrease in ambulation, rearing, and 
grooming frequencies was recorded in OPT after 
induction of depression using CUS model in mice and 
rats. In the current study, the depressed group showed 
an increase in the immobility duration in FST and TST. 
Similar results were obtained by Ran et al. [20]. In 
the present study, treatment with fluoxetine improved 
the depressed condition induced by the CUS where 
it stored the ambulation, grooming frequencies, and 
latency time and increased the rearing frequency 
significantly as compared to CUS-induced group. 
Furthermore, the immobility duration was normalized in 
both FST and TST. These observations are consistent 
with the results obtained from a previous study [21]. 
A-LA given in a dose of 300 mg/kg bwt. decreased 
the latency time significantly as compared to CUS-
induced group and normalized the ambulation, rearing, 
and grooming frequencies. In the FST and TST, A-LA 
normalized the immobility duration. The overall results 
were comparable to those of fluoxetine. These results 
might be due to A-LAs content of Trp. In a previous 
Trp, potential antidepressant effect was investigated 
in mice using FST and OPT. Results showed that Trp 
in revealed an antidepressant effect and this effect 
increased by increase the dose of Trp till 125 mg/kg bwt. 
Authors explained these results that Trp is a precursor 
of SE so by increasing Trp, the SE, in turn, will increase 
and though elevating the animal’s mood [22].
In the present study, depressed animals showed 
a significant decrease in brain SE, NE, DA, and Glu. 
On the contrary, GABA was increased. Similar findings 
revealed that the application of CUS on mice resulted in 
significant reduction of NE and  DA in the hippocampus 
and prefrontal cortex in rat brains. Moreover, findings 
showed that CUS reduced levels of glutamine and Glu in 
the prefrontal cortex and the ratio of Glu and Glu/GABA 
was also reduced in the hippocampus [8]. Administration 
of fluoxetine in our study restored the levels of SE, NE, 
and DA, and moreover, it increased the level of Glu 
while the level of GABA was significantly reduced as 
compared to depressed group. These results agreed 
with those of Bymaster et al. [23] and Lazarevic et al. [24] 
who reported that in rat prefrontal cortex, acute systemic 
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Figure 6: Determination of glutathione and malondialdehyde. Values 
represent the mean % of five mice for each group (n = 10). @p < 0.05: 
Statistically significant from normal control, *p < 0.05: Statistically 
significant from depressed group
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administration of fluoxetine produced a continuous 
elevation in NE and DA levels. In another study, it was 
reported that fluoxetine increased levels of both SE and 
NE levels [25]. Several studies showed that 5-HT2C 
receptors localized on GABA cells in the raphe nucleus 
facilitate GABA [26]. A-LA (300 mg/kg) highly elevated the 
monoamines concentrations as compared to the control 
group. Moreover, A-LA treatment was more potent than 
fluoxetine regarding NE and DA levels. GABA level was 
normalized while Glu level was significantly elevated 
compared to the normal control. The current results 
agreed with results obtained from a previous study 
which reported that the administration of A-LA enhanced 
SE release and rewarding effect, though improving the 
mood [27]. Moreover, besides being rich in Trp, A-LA 
also is rich in glutamine, phenylalanine, and tyrosine [6]. 
Glutamine is abundantly found in CNS and plays a major 
role in the synthesis of Glu, aspartate, and GABA [28].
In the current study, the stressed group showed 
that MDA level was significantly increased while the 
reduced GSH was significantly decreased indicating that 
causal relation between oxidative stress and depression. 
Our findings agreed with those of Duda et al. [29] where 
depression was induced using CUS model for 21 days 
showed an increase in MDA and reduction in GSH 
concentrations in brain tissue. On the contrary, group 
given fluoxetine restored the GSH and MDA levels when 
compared to stress group representing an antioxidant 
effect. This finding is in rhyme with the previous results, 
indicating that SE exerts a protective effect against 
oxidative damage in nerve cells [30]. It has been reported 
in a previous study on mice that long-term treatment for 
28 days with fluoxetine (10 mg/kg, p.o.) increased the 
GSH levels in the hippocampus [31]. In another study, 
mice subjected to CUS when treated with fluoxetine for 
24 days showed markedly reduced MDA levels [32]. 
GSH level was normalized and MDA level was also 
significantly decreased by the administration of A-LA in 
a dose of 300 mg/kg bwt. as compared to the control 
group. In a previous study, it was found that A-LA is rich 
in the essential amino acids cysteine and glycine which 
are the precursor of GSH [6]. Further studies including 
its effects on the specific transport of A-LA into brain of 
Wistar rats or in other strains, also the potential use of 
A-LA in clinical depression is recommended.
Further investigations are recommended 
to study the mechanism of action of A-LA on brain 
neurotransmitters in terms of release, uptake, and 
metabolism. In addition, it is important to evaluate its 
applicability to be used as an antidepressant drug.
 Conclusion
A-LA administered at a dose level of 300 mg/kg 
showed significant effects against the depressive symptoms 
induced in mice by applying the CUS model and its effect 
was comparable to that of fluoxetine. The antioxidant 
potential of A-LA could contribute, in part, in ameliorating 
the depressive symptoms.
References
1. Hedden SL. Behavioral Health Trends in the United States: 
Results from the 2014 National Survey on Drug Use and Health. 
United States: Substance Abuse and Mental Health Services 
Administration, Department of Health and Human Services; 
2015. https://doi.org/10.3886/icpsr32722.v3
2. Brunello N, Mendlewicz J, Kasper S, Leonard B, Montgomery S, 
Nelson J, et al. The role of noradrenaline and selective 
noradrenaline reuptake inhibition in depression. Eur 
Neuropsychopharmacol. 2002;12(5):461-75. https://doi.
org/10.1016/s0924-977x(02)00057-3
 PMid:12208564
3. Wang Q, Timberlake MA 2nd, Prall K, Dwivedi Y. The 
recent progress in animal models of depression. Prog 
Neuropsychopharmacol Biol Psychiatry. 2017;77:99-109. 
https://doi.org/10.1016/j.pnpbp.2017.04.008
 PMid:28396255
4. Black CN, Bot M, Scheffer PG, Penninx BW. Oxidative stress 
in major depressive and anxiety disorders, and the association 
with antidepressant use; results from a large adult cohort. 
Psychol Med. 2017;47(5):936-48. https://doi.org/10.1017/
s0033291716002828
 PMid:27928978
5. Yamaguchi M, Yoshida K, Uchida M. Novel functions of bovine 
milk-derived alpha-lactalbumin: Anti-nociceptive and anti-
inflammatory activity caused by inhibiting cyclooxygenase-2 
and phospholipase A2. Biol Pharm Bull. 2009;32(3):366-71. 
https://doi.org/10.1248/bpb.32.366
 PMid:19252279
6. Layman DK, Lönnerdal B, Fernstrom JD. Applications for 
α-lactalbumin in human nutrition. Nutr Rev. 2018;76(6):444-60. 
https://doi.org/10.1093/nutrit/nuy004
 PMid:29617841
7. Mao QQ, Ip SP, Ko KM, Tsai SH, Xian YF, Che CT. 
Effects of peony glycosides on mice exposed to chronic 
unpredictable stress: Further evidence for antidepressant-
like activity. J Ethnopharmacol. 2009;124(2):316-20. 
https://doi.org/10.1016/j.jep.2009.04.019
 PMid:19375493
8. Ahmed RF, Eldenshary EE, Nada SA, Asaad GF, Arafa NM, 
Farid OA. Pharmacological study of the possible antidepressant 
activity of whey protein isolate in mice. Aust J Basic Appl Sci. 
2011;5(12):2649-59.
9. Zeldetz V, Natanel D, Boyko M, Zlotnik A, Shiyntum HN, Grinshpun J, 
et al. A new method for inducing a depression-like behavior in rats. 
J Vis Exp. 2018;132:1-8. https://doi.org/10.3791/57137
 PMid:29553503
10. Kwak C, Lee SH, Kaang BK. Social isolation selectively 
increases anxiety in mice without affecting depression-like 
behavior. Korean J Physiol Pharmacol. 2009;13(5):357-60. 
https://doi.org/10.4196/kjpp.2009.13.5.357
 PMid:19915697
11. Can A, Dao DT, Terrillion CE, Piantadosi SC, Bhat S, Gould TD. 
The tail suspension test. J Vis Exp. 2012;59:e3769.
 PMid:22315011
 Asaadetal.EffectofAlpha-lactalbuminonStressModelinMice
Open Access Maced J Med Sci. 2020 Mar 25; 8(A):93-99. 99
12. Yankelevitch-Yahav R, Franko M, Huly A, Doron R. The 
forced swim test as a model of depressive-like behavior. J Vis 
Exp. 2015;97:1-7. https://doi.org/10.3791/52587
 PMid:25867960
13. Arafa N, Salem S, Farid OA. Influence of Echinacea extract 
pre-or postnatal supplementation on immune and oxidative 
status of growing rabbits. Ital J Anim Sci. 2010;9(3):E63.
14. Zieminska E, Toczylowska B, Diamandakis D, Hilgier W, 
Filipkowski RK, Polowy R, et al. Glutamate, glutamine and 
GABA levels in rat brain measured using MRS, HPLC and NMR 
methods in study of two models of autism. Front Mol Neurosci. 
2018;11:418. https://doi.org/10.3389/fnmol.2018.00418
 PMid:30505268
15. Viljoen FP, du Preez JL, Wessels JC, Aucamp ME. HPLC 
electrochemical detection and quantification of monoamines 
and their metabolites in rat brain tissue samples. Pharmazie. 
2018;73(10):563-9.
 PMid:30223919
16. Ruiz-Larrea MB, Leal AM, Liza M, Lacort M, de Groot H. Antioxidant 
effects of estradiol and 2-hydroxyestradiol on iron-induced lipid 
peroxidation of rat liver microsomes. Steroids. 1994;59(6):383-
8. https://doi.org/10.1016/0039-128x(94)90006-x
 PMid:7940617
17. Bulaj G, Kortemme T, Goldenberg DP. Ionization-reactivity 
relationships for cysteine thiols in polypeptides. Biochemistry. 
1998;37(25):8965-72. https://doi.org/10.1021/bi973101r
 PMid:9636038
18. Castagné V, Moser P, Roux S, Porsolt RD. Rodent models of 
depression: Forced swim and tail suspension behavioral despair 
tests in rats and mice. Curr Protoc Neurosci. 2011; 8:8.10A. 
https://doi.org/10.1002/0471142301.ns0810as55
 PMid:21462162
19. Sequeira-Cordero A, Salas-Bastos A, Fornaguera J, Brenes JC. 
Behavioural characterisation of chronic unpredictable 
stress based on ethologically relevant paradigms in 
rats. Sci Rep. 2019;9(1):17403. https://doi.org/10.1038/
s41598-019-53624-1
 PMid:31758000
20. Ran Y, Jin Z, Chen X, Zhao N, Fang X, Zhang L, et al. Hypidone 
hydrochloride (YL-0919) produces a fast-onset reversal of 
the behavioral and synaptic deficits caused by chronic stress 
exposure. Front Cell Neurosci. 2018;12:395. https://doi.
org/10.3389/fncel.2018.00395
 PMid:30524234
21. Monteiro S, Roque S, de Sá-Calçada D, Sousa N, Correia-
Neves M, Cerqueira JJ. An efficient chronic unpredictable 
stress protocol to induce stress-related responses in C57BL/6 
mice. Front Psychiatry. 2015;6:6. https://doi.org/10.3389/
fpsyt.2015.00006
 PMid:25698978
22. Chen Y, Xu H, Zhu M, Liu K, Lin B, Luo R, et al. Stress inhibits 
tryptophan hydroxylase expression in a rat model of depression. 
Oncotarget. 2017;8(38):63247-57. https://doi.org/10.18632/
oncotarget.18780
 PMid:28968985
23. Bymaster FP, Katner JS, Nelson DL, Hemrick-Luecke SK, 
Threlkeld PG, Heiligenstein JH, et al. Atomoxetine 
increases extracellular levels of norepinephrine and 
dopamine in prefrontal cortex of rat: A potential mechanism 
for efficacy in attention deficit/hyperactivity disorder. 
Neuropsychopharmacology. 2002;27(5):699-711. https://doi.
org/10.1016/s0893-133x(02)00346-9
 PMid:12431845
24. Lazarevic V, Mantas I, Flais I, Svenningsson P. Fluoxetine 
suppresses glutamate-and GABA-mediated neurotransmission 
by altering SNARE complex. Int J Mol Sci. 2019;20(17):E4247. 
https://doi.org/10.3390/ijms20174247
 PMid:31480244
25. Kobayashi K, Ikeda Y, Sakai A, Yamasaki N, Haneda E, 
Miyakawa T, et al. Reversal of hippocampal neuronal 
maturation by serotonergic antidepressants. Proc Natl 
Acad Sci. 2010;107(18):8434-9. https://doi.org/10.1073/
pnas.0912690107
26. Martin CB, Martin VS, Trigo JM, Chevarin C, Maldonado R, 
Fink LH, et al. 5-HT2C receptor desensitization moderates 
anxiety in 5-HTT deficient mice: From behavioral to cellular 
evidence. Int J Neuropsychopharmacol. 2014;18(3):pyu056. 
https://doi.org/10.1093/ijnp/pyu056
 PMid:25522398
27. Orosco M, Rouch C, Beslot F, Feurte S, Regnault A, Dauge V. 
Alpha-lactalbumin-enriched diets enhance serotonin release 
and induce anxiolytic and rewarding effects in the rat. 
Behav Brain Res. 2004;148(1-2):1. https://doi.org/10.1016/
s0166-4328(03)00153-0
 PMid:14684242
28. Albrecht J, Sidoryk-Węgrzynowicz M, Zielińska M, Aschner M. 
Roles of glutamine in neurotransmission. Neuron Glia Biol. 
2010;6(4):263-76. https://doi.org/10.1017/s1740925x11000093
29. Duda W, Curzytek K, Kubera M, Iciek M, Kowalczyk-Pachel D, 
Bilska-Wilkosz A, et al. The effect of chronic mild stress and 
imipramine on the markers of oxidative stress and antioxidant 
system in rat liver. Neurotox Res. 2016;30(2):173-84. https://doi.
org/10.1007/s12640-016-9614-8
 PMid:26961706
30. Jiang J, Yu S, Jiang Z, Liang C, Yu W, Li J, et al. N-acetyl-
serotonin protects HepG2 cells from oxidative stress injury 
induced by hydrogen peroxide. Oxid Med Cell Longev. 
2014;2014:310504. https://doi.org/10.1155/2014/310504
 PMid:25013541
31. Freitas AE, Budni J, Lobato KR, Binfaré RW, Machado DG, 
Jacinto J, et al. Antidepressant-like action of the ethanolic extract 
from Tabebuia avellanedae in mice: Evidence for the involvement 
of the monoaminergic system. Prog Neuropsychopharmacol 
Biol Psychiatry. 2010;34(2):335-43. https://doi.org/10.1016/j.
pnpbp.2009.12.010
 PMid:20026371
32. Ahmed-Farid O, Ahmed R, Saleh D. Combination of resveratrol 
and fluoxetine in an acute model of depression in mice: 
Prevention of oxidative DNA fragmentation and monoamines 
degradation. J Appl Pharm Sci. 2016;6:1-7. https://doi.
org/10.7324/japs.2016.60601
